Fig. 3From: Inhibition of CDK4/6 as a novel therapeutic option for neuroblastomaAssessment of cellular proliferation after treatment with palbociclib. The cellular proliferation data was measured in real time using the xCELLigence system. The data shown represents the percentage of cellular proliferation 48 h after treatment with palbociclib. Error bars represent the standard deviation (n = 2).Back to article page